Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

312 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase II study of FOLFOX combined with nab-paclitaxel in the treatment of metastatic or advanced unresectable gastric, gastroesophageal junction adenocarcinoma: a Big Ten Cancer Research Consortium trial.
Dreyer MS, Mulcahy M, Kocherginsky M, Chen Y, Hochster HS, Kasi PM, Kircher S, Lou E, Ma Y, Uboha NV, Benson AB 3rd. Dreyer MS, et al. Among authors: benson ab 3rd. Oncologist. 2024 Sep 18:oyae236. doi: 10.1093/oncolo/oyae236. Online ahead of print. Oncologist. 2024. PMID: 39293067 Free article.
A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms: Results from ECOG-ACRIN E1Z11.
Stearns V, Jegede OA, Chang VT, Skaar TC, Berenberg JL, Nand R, Shafqat A, Jacobs NL, Luginbuhl W, Gilman P, Benson AB 3rd, Goodman JR, Buchschacher GL Jr, Henry NL, Loprinzi CL, Flynn PJ, Mitchell EP, Fisch MJ, Sparano JA, Wagner LI. Stearns V, et al. Among authors: benson ab 3rd. Clin Cancer Res. 2024 Jul 1;30(13):2709-2718. doi: 10.1158/1078-0432.CCR-23-2137. Clin Cancer Res. 2024. PMID: 38640040
Defining the Role of the Advanced Practice Provider Within the National Cancer Institute Community Oncology Research Program.
Braun-Inglis CM, Dressler EV, Myers JS, Benson AB 3rd, Flannery M, Good M, Denicoff A, Berenberg JL, DeTroye AT, O'Brien B, Kottschade L, Omatsu DA, Kittel CA, Nightingale CL, Foust M, Lesser GJ. Braun-Inglis CM, et al. Among authors: benson ab 3rd. JCO Oncol Pract. 2024 Feb;20(2):239-246. doi: 10.1200/OP.23.00501. Epub 2024 Jan 4. JCO Oncol Pract. 2024. PMID: 38175992
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200.
Giantonio BJ, Catalano PJ, Meropol NJ, O'Dwyer PJ, Mitchell EP, Alberts SR, Schwartz MA, Benson AB 3rd. Giantonio BJ, et al. Among authors: benson ab 3rd. J Clin Oncol. 2023 Jul 20;41(21):3670-3675. doi: 10.1200/JCO.22.02761. J Clin Oncol. 2023. PMID: 37459754 Clinical Trial.
Disparities in gastrointestinal cancers.
Chiec L, Benson AB 3rd. Chiec L, et al. Among authors: benson ab 3rd. J Natl Med Assoc. 2023 May;115(2S):S13-S18. doi: 10.1016/j.jnma.2023.02.002. J Natl Med Assoc. 2023. PMID: 37201999 No abstract available.
An Assessment of the Feasibility and Utility of an ACCC-ASCO Implicit Bias Training Program to Enhance Racial and Ethnic Diversity in Cancer Clinical Trials.
Barrett NJ, Boehmer L, Schrag J, Benson AB 3rd, Green S, Hamroun-Yazid L, Howson A, Matin K, Oyer RA, Pierce L, Jeames SE, Winkfield K, Yang ES, Zwicker V, Bruinooge S, Hurley P, Williams JH, Guerra CE. Barrett NJ, et al. Among authors: benson ab 3rd. JCO Oncol Pract. 2023 Apr;19(4):e570-e580. doi: 10.1200/OP.22.00378. Epub 2023 Jan 11. JCO Oncol Pract. 2023. PMID: 36630671
312 results